Articles
Page 40 of 40
-
Citation: Clinical Epigenetics 2011 2:48
-
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
The myeloproliferative neoplasms (MPNs) are a group of clonal hematological malignancies characterized by a hypercellular bone marrow and a tendency to develop thrombotic complications and to evolve to myelofi...
Citation: Clinical Epigenetics 2011 2:50 -
Exposure and fetal growth-associated miRNA alterations in the human placenta
Researchers have begun to examine epigenetic alterations in the placenta, making key advances in understanding the epigenetic regulatory mechanisms of the placenta that define underlying processes of human dev...
Citation: Clinical Epigenetics 2011 2:46 -
Role of DNA methylation in head and neck cancer
Head and neck cancer (HNC) is a heterogenous and complex entity including diverse anatomical sites and a variety of tumor types displaying unique characteristics and different etilogies. Both environmental and...
Citation: Clinical Epigenetics 2011 2:45 -
MicroRNA-mediated drug resistance in breast cancer
Chemoresistance is one of the major hurdles to overcome for the successful treatment of breast cancer. At present, there are several mechanisms proposed to explain drug resistance to chemotherapeutic agents, i...
Citation: Clinical Epigenetics 2011 2:40 -
H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues
A sequence variant of histone H2A called H2AX is one of the key components of chromatin involved in DNA damage response induced by different genotoxic stresses. Phosphorylated H2AX (γH2AX) is rapidly concentra...
Citation: Clinical Epigenetics 2011 2:44 -
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia
Epigenetic mechanisms such as DNA hypermethylation and modifications of histone amino acids are known to play an important role in the control of gene expression both in normal human development and tumorigene...
Citation: Clinical Epigenetics 2011 2:43 -
Epigenetic regulation of prostate cancer
Prostate cancer is a commonly diagnosed cancer in men and a leading cause of cancer deaths. Whilst the underlying mechanisms leading to prostate cancer are still to be determined, it is evident that both genet...
Citation: Clinical Epigenetics 2011 2:41 -
Evolutional and clinical implications of the epigenetic regulation of protein glycosylation
Protein N glycosylation is an ancient posttranslational modification that enriches protein structure and function. The addition of one or more complex oligosaccharides (glycans) to the backbones of the majorit...
Citation: Clinical Epigenetics 2011 2:39 -
Insufficient DNA methylation affects healthy aging and promotes age-related health problems
DNA methylation plays an integral role in development and aging through epigenetic regulation of genome function. DNA methyltransferase 1 (Dnmt1) is the most prevalent DNA methyltransferase that maintains geno...
Citation: Clinical Epigenetics 2011 2:42 -
Transcriptional modulation by VIP: a rational target against inflammatory disease
Vasoactive intestinal peptide (VIP) is a pleiotropic, highly conserved, peptide found in many different biological systems throughout invertebrate phyla. VIP is produced by cells of the immune system but also ...
Citation: Clinical Epigenetics 2011 2:36 -
ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients
Elevated activation of the platelet-derived growth factor (PDGF) pathway, apoptosis evasion phenotype, and global DNA hypomethylation are hallmarks frequently observed in cancers, such as in low-grade glioma (...
Citation: Clinical Epigenetics 2011 2:35 -
Epigenetic management of major psychosis
Epigenetic mechanisms are thought to play a major role in the pathogenesis of the major psychoses (schizophrenia and bipolar disorder), and they may be the link between the environment and the genome in the pa...
Citation: Clinical Epigenetics 2011 2:38 -
Epigenetic regulation of mucin genes in human cancers
Mucins are high molecular weight glycoproteins that play important roles in diagnostic and prognostic prediction and in carcinogenesis and tumor invasion. Regulation of expression of mucin genes has been studi...
Citation: Clinical Epigenetics 2011 2:37 -
Modulation of gene-specific epigenetic states and transcription by non-coding RNAs
Emerging evidence points to a role for long non-coding RNAs in the modulation of epigenetic states and transcription in human cells. New insights, using various forms of small non-coding RNAs, suggest that a m...
Citation: Clinical Epigenetics 2011 2:34 -
The role of epigenetic dysregulation in the epidemic of allergic disease
The epidemic of allergic disease in early life is one of the clearest indicators that the developing immune system is vulnerable to modern environmental changes. A range of environmental exposures epidemiologi...
Citation: Clinical Epigenetics 2011 2:28 -
Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications
Epigenetic changes in long interspersed nuclear element-1s (LINE-1s or L1s) occur early during the process of carcinogenesis. A lower methylation level (hypomethylation) of LINE-1 is common in most cancers, an...
Citation: Clinical Epigenetics 2011 2:32 -
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
5-azacytidine (AZA) has become standard treatment for patients with higher-risk myelodysplastic syndrome (MDS). Response rate is about 50% and response duration is limited. Histone deactylase (HDAC) inhibitors...
Citation: Clinical Epigenetics 2011 2:31 -
Can metabolic plasticity be a cause for cancer? Warburg–Waddington legacy revisited
Fermentation of glucose to lactate in the presence of sufficient oxygen, known as aerobic glycolysis or Warburg effect, is a universal phenotype of cancer cells. Understanding its origin and role in cellular i...
Citation: Clinical Epigenetics 2011 2:30 -
Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels
Lymphocytes from the peripheral blood of patients with prostate cancer—the most frequent (noncutaneous) tumor in men—display epigenetic aberrations (altered modes of allelic replication) characteristic of the ...
Citation: Clinical Epigenetics 2011 2:29 -
Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation
Epithelial cells lining the adult colon do not normally express gastrin-releasing peptide (GRP) or its receptor (GRPR). In contrast, GRP/GRPR can be aberrantly expressed in human colorectal cancer (CRC) includ...
Citation: Clinical Epigenetics 2011 2:27 -
Epigenetic mechanisms in virus-induced tumorigenesis
About 15–20% of human cancers worldwide have viral etiology. Emerging data clearly indicate that several human DNA and RNA viruses, such as human papillomavirus, Epstein–Barr virus, Kaposi’s sarcoma-associated...
Citation: Clinical Epigenetics 2011 2:26 -
The biological basis and clinical significance of hormonal imprinting, an epigenetic process
The biological phenomenon, hormonal imprinting, was named and defined by us (Biol Rev, 1980, 55, 47-63) 30 years ago, after many experimental works and observations. Later, similar phenomena were also named to...
Citation: Clinical Epigenetics 2011 2:24 -
Targeting Huntington’s disease through histone deacetylases
Huntington’s disease (HD) is a debilitating neurodegenerative condition with significant burdens on both patient and healthcare costs. Despite extensive research, treatment options for patients with this condi...
Citation: Clinical Epigenetics 2011 2:25 -
The elements of human cyclin D1 promoter and regulation involved
Cyclin D1 is a cell cycle machine, a sensor of extracellular signals and plays an important role in G1-S phase progression. The human cyclin D1 promoter contains multiple transcription factor binding sites suc...
Citation: Clinical Epigenetics 2011 2:18 -
Impact of vitamin D metabolism on clinical epigenetics
The bioactive vitamin D (VD) metabolite, 1,25-dihydroxyvitamin D3 regulates essential pathways of cellular metabolism and differentiation via its nuclear receptor (VDR). Molecular mechanisms which are known to pl...
Citation: Clinical Epigenetics 2011 2:21 -
The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention
Histone deacetylases (HDACs) are homologous to prokaryotic enzymes that removed acetyl groups from non-histone proteins before the evolution of eukaryotic histones. Enzymes inherited from prokaryotes or from a...
Citation: Clinical Epigenetics 2011 2:20 -
5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer
While studying on epigenetic regulatory mechanisms (DNA methylation at C-5 of –CpG– cytosine and demethylation of methylated DNA) of certain genes (FAS, CLU, E-cadh, CD44, and Cav-1) associated with prostate c...
Citation: Clinical Epigenetics 2011 2:19 -
Interaction of SET domains with histones and nucleic acid structures in active chromatin
Changes in the normal program of gene expression are the basis for a number of human diseases. Epigenetic control of gene expression is programmed by chromatin modifications—the inheritable “histone code”—the ...
Citation: Clinical Epigenetics 2011 2:15 -
Epigenetic mechanisms and genome stability
Epigenetic marks are well recognized as heritable chemical modifications of DNA and chromatin that induce chromatin structural changes thereby affecting gene activity. A lesser-known phenomenon is the pervasiv...
Citation: Clinical Epigenetics 2010 2:17 -
Molecular marks for epigenetic identification of developmental and cancer stem cells
Epigenetic regulations of genes by reversible methylation of DNA (at the carbon-5 of cytosine) and numerous reversible modifications of histones play important roles in normal physiology and development, and e...
Citation: Clinical Epigenetics 2010 2:16 -
The possibility of evidence-based psychiatry: depression as a case
Considering psychiatry as a medical discipline, a diagnosis identifying a disorder should lead to an effective therapy. Such presumed causality is the basis of evidence-based psychiatry. We examined the streng...
Citation: Clinical Epigenetics 2010 2:14 -
Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC)
Incorporation of viral DNA may interfere with the normal sequence of human DNA bases on the genetic level or cause secondary epigenetic changes such as gene promoter methylation or histone acetylation. Colorec...
Citation: Clinical Epigenetics 2010 2:13 -
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Heritable changes in gene expression that are not based upon alterations in the DNA sequence are defined as epigenetics. The most common mechanisms of epigenetic regulation are the methylation of CpG islands w...
Citation: Clinical Epigenetics 2010 1:12 -
Epigenetic targets of bioactive dietary components for cancer prevention and therapy
The emergent interest in cancer epigenetics stems from the fact that epigenetic modifications are implicated in virtually every step of tumorigenesis. More interestingly, epigenetic changes are reversible heri...
Citation: Clinical Epigenetics 2010 1:11 -
Cancer: evolutionary, genetic and epigenetic aspects
There exist two paradigms about the nature of cancer. According to the generally accepted one, cancer is a by-product of design limitations of a multi-cellular organism (Greaves, Nat Rev Cancer 7:213–221, 2007...
Citation: Clinical Epigenetics 2010 1:10 -
Introductory editorial
Citation: Clinical Epigenetics 2010 1:9 -
The sirtuins in the pathogenesis of cancer
Aging is the natural trace that time leaves behind on life during blossom and maturation, culminating in senescence and death. This process is accompanied by a decline in the healthy function of multiple organ...
Citation: Clinical Epigenetics 2010 1:8 -
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Histone modifications have widely been implicated in cancer development and progression and are potentially reversible by drug treatments. The N-terminal tails of each histone extend outward through the DNA st...
Citation: Clinical Epigenetics 2010 1:6 -
Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cells
Epigenetic treatment concepts have long been ascribed as being tumour-selective. Over the last decade, it has become evident that epigenetic mechanisms are essential for a wide range of intracellular functions...
Citation: Clinical Epigenetics 2010 1:7 -
DNA hypermethylation markers of poor outcome in laryngeal cancer
This study examined molecular (DNA hypermethylation), clinical, histopathological, demographical, smoking, and alcohol variables to assess diagnosis (early versus late stage) and prognosis (survival) outcomes ...
Citation: Clinical Epigenetics 2010 1:5 -
Continuous multiparametric monitoring of cell metabolism in response to transient overexpression of the sirtuin deacetylase SIRT3
The analysis and visualisation of research data in an environment which is most similar to living conditions belong to the most challenging claims of present scientific research endeavours. To date, the effect...
Citation: Clinical Epigenetics 2010 1:4 -
Histone deacetylases in viral infections
Chromatin remodeling and gene expression are regulated by histone deacetylases (HDACs) that condense the chromatin structure by deacetylating histones. HDACs comprise a group of enzymes that are responsible fo...
Citation: Clinical Epigenetics 2010 1:3 -
Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?
Citation: Clinical Epigenetics 2010 1:2 -
Challenge and promise: the role of miRNA for pathogenesis and progression of malignant melanoma
microRNAs are endogenous noncoding RNAs that are implicated in gene regulation. More recently, miRNAs have been shown to play a pivotal role in multiple cellular processes that interfere with tumorigenesis. He...
Citation: Clinical Epigenetics 2010 1:1
Follow
- ISSN: 1868-7083 (electronic)